Marketa Zvelebil

11.9k total citations · 1 hit paper
102 papers, 8.2k citations indexed

About

Marketa Zvelebil is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Marketa Zvelebil has authored 102 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 24 papers in Oncology and 15 papers in Cell Biology. Recurrent topics in Marketa Zvelebil's work include Protein Kinase Regulation and GTPase Signaling (12 papers), Bioinformatics and Genomic Networks (12 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Marketa Zvelebil is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), Bioinformatics and Genomic Networks (12 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). Marketa Zvelebil collaborates with scholars based in United Kingdom, United States and Switzerland. Marketa Zvelebil's co-authors include Michael D. Waterfield, Matthias P. Wymann, Michael J.E. Sternberg, Bart Vanhaesebroeck, Robert C. Stein, George Panayotou, Stefano Volinia, Muriel Laffargue, Luciano Pirola and Geoffrey J. Barton and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Marketa Zvelebil

100 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wortmannin Inactivates Phosphoinositide 3-Kinase by Covalent Modification of Lys-802, a Residue Involved in the Phosphate Transfer Reaction

1996 591 citations Matthias P. Wymann, Marketa Zvelebil et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marketa Zvelebil United Kingdom	49	5.8k	1.6k	1.2k	1.1k	863	102	8.2k
Jarrod A. Marto United States	62	7.9k 1.4×	2.0k 1.3×	1.1k 0.9×	1.4k 1.2×	909 1.1×	172	11.3k
David T. Weaver United States	49	6.5k 1.1×	2.6k 1.7×	747 0.6×	1.4k 1.2×	1.3k 1.5×	150	9.0k
Edward V. Prochownik United States	53	6.4k 1.1×	2.1k 1.3×	804 0.7×	902 0.8×	1.8k 2.0×	170	8.6k
Edward Y. Skolnik United States	52	7.5k 1.3×	1.6k 1.0×	2.1k 1.8×	1.6k 1.4×	668 0.8×	84	11.2k
Krister Wennerberg Finland	48	6.5k 1.1×	1.5k 0.9×	2.3k 2.0×	963 0.9×	1.1k 1.3×	153	10.5k
Henrik Daub Germany	35	5.4k 0.9×	1.7k 1.1×	1.1k 1.0×	705 0.6×	524 0.6×	56	7.6k
Estela Jacinto United States	27	6.9k 1.2×	906 0.6×	965 0.8×	1.5k 1.3×	895 1.0×	45	8.9k
Alan P. Fields United States	54	6.1k 1.0×	1.8k 1.2×	1.4k 1.2×	612 0.5×	1.1k 1.2×	120	7.9k
Peter van der Geer United States	38	5.5k 1.0×	1.5k 1.0×	1.9k 1.6×	1.3k 1.2×	920 1.1×	62	8.3k
Irina Kratchmarova Denmark	28	6.8k 1.2×	963 0.6×	1.0k 0.9×	1.2k 1.0×	908 1.1×	54	9.4k

Countries citing papers authored by Marketa Zvelebil

Since Specialization

Citations

This map shows the geographic impact of Marketa Zvelebil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marketa Zvelebil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marketa Zvelebil more than expected).

Fields of papers citing papers by Marketa Zvelebil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marketa Zvelebil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marketa Zvelebil. The network helps show where Marketa Zvelebil may publish in the future.

Co-authorship network of co-authors of Marketa Zvelebil

This figure shows the co-authorship network connecting the top 25 collaborators of Marketa Zvelebil. A scholar is included among the top collaborators of Marketa Zvelebil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marketa Zvelebil. Marketa Zvelebil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murugaesu, Nirupa, Marjan Iravani, Antoinette van Weverwijk, et al.. (2014). An In Vivo Functional Screen Identifies ST6GalNAc2 Sialyltransferase as a Breast Cancer Metastasis Suppressor. Cancer Discovery. 4(3). 304–317. 75 indexed citations

Gao, Qiong, Neill Patani, Anita K. Dunbier, et al.. (2014). Effect of Aromatase Inhibition on Functional Gene Modules in Estrogen Receptor–Positive Breast Cancer and Their Relationship with Antiproliferative Response. Clinical Cancer Research. 20(9). 2485–2494. 31 indexed citations

Zvelebil, Marketa, Erik Oliemuller, Qiong Gao, et al.. (2013). Embryonic mammary signature subsets are activated in Brca1 -/- and basal-like breast cancers. Breast Cancer Research. 15(2). R25–R25. 51 indexed citations

Morandi, Andrea, Lesley‐Ann Martin, Qiong Gao, et al.. (2013). GDNF–RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors. Cancer Research. 73(12). 3783–3795. 83 indexed citations

Myronakis, Marios, et al.. (2013). Normalized mean glandular dose computation from mammography using GATE: a validation study. Physics in Medicine and Biology. 58(7). 2247–2265. 17 indexed citations

Zimmermann, Mirjam, Olivier Jacques, Matthias Wittwer, et al.. (2013). Chemical Development of Intracellular Protein Heterodimerizers. Chemistry & Biology. 20(4). 549–557. 49 indexed citations

Ur-Rehman, Saif, Qiong Gao, Costas Mitsopoulos, & Marketa Zvelebil. (2013). ROCK: a resource for integrative breast cancer data analysis. Breast Cancer Research and Treatment. 139(3). 907–921. 27 indexed citations

Sims, David, et al.. (2010). The FLIGHT Drosophila RNAi database. Fly. 4(4). 344–348. 2 indexed citations

Banerjee, Susana, Marketa Zvelebil, Pascal Furet, et al.. (2009). The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase. Cancer Research. 69(11). 4716–4723. 21 indexed citations

10.

Folkes, Adrian, Stewart Baker, Irina Chuckowree, et al.. (2008). The discovery of GDC-0941: A potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. Cancer Research. 68. 5 indexed citations

11.

Reynolds, C. Hugh, Claire J. Garwood, Selina Wray, et al.. (2008). Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases. Journal of Biological Chemistry. 283(26). 18177–18186. 186 indexed citations

12.

Kendrick, Howard, Joseph L. Regan, Anita Grigoriadis, et al.. (2008). Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics. 9(1). 591–591. 142 indexed citations

13.

Datta, Susmita, Andrew McQuillin, Mie Rizig, et al.. (2008). A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Molecular Psychiatry. 15(6). 615–628. 45 indexed citations

14.

Zhukovskaya, Natasha V., Masashi Fukuzawa, Masatsune Tsujioka, et al.. (2003). Dd-STATb, a Dictyostelium STAT protein with a highly aberrant SH2 domain, functions as a regulator of gene expression during growth and early development. Development. 131(2). 447–458. 23 indexed citations

15.

Williamson, Ritchie, et al.. (2002). Tau binds to phosphatidylinositol-3-kinase, GRB2 phospholipase C gamma-1 and SRC-family kinases through SH3 domain. Neurobiology of Aging. 23(1). 1 indexed citations

16.

Stein, Robert C. & Marketa Zvelebil. (2002). The Application of 2D Gel-Based Proteomics Methods to the Study of Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 7(4). 385–393. 21 indexed citations

17.

Arcaro, Alexandre, Marketa Zvelebil, Christian Wallasch, et al.. (2000). Class II Phosphoinositide 3-Kinases Are Downstream Targets of Activated Polypeptide Growth Factor Receptors. Molecular and Cellular Biology. 20(11). 3817–3830. 136 indexed citations

18.

Zvelebil, Marketa, Lindsay K. MacDougall, Sally J. Leevers, et al.. (1996). Structural and functional diversity of phosphoinositide 3-kinases. Philosophical Transactions of the Royal Society B Biological Sciences. 351(1336). 217–223. 86 indexed citations

19.

Thornton, Janet M., Malcolm W. MacArthur, D. T. Jones, et al.. (1993). Protein structures and complexes: what they reveal about the interactions that stabilize them. Philosophical Transactions of the Royal Society of London Series A Physical and Engineering Sciences. 345(1674). 113–129. 12 indexed citations

20.

Sternberg, Michael J.E. & Marketa Zvelebil. (1990). Prediction of protein structure from sequence. European Journal of Cancer and Clinical Oncology. 26(11-12). 1163–1166. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact